Aristo Pharma Nordic ApS: Financial statements 2021
CVR: 32328768
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Aristo Pharma Nordic ApS (CVR 32328768) has filed annual accounts for 2021. In 2021, the company reported a gross profit of EUR 789,373 and a net result of EUR 45,333 compared with EUR 62,127 the year before. That is a decrease of 1.9% compared with the year before. Equity in the 2021 report amounted to EUR 60,722. The solvency ratio was 12.3%. The company had 7 employees in the financial year.
- Gross Profit
- EUR 789,373
- Profit/Loss
- EUR 45,333
- Equity
- EUR 60,722
- Total Assets
- EUR 495,436
- Employees
- 7
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 789K EUR | 45K EUR | 61K EUR | 7 |
| 2020 | - | 805K EUR | 62K EUR | -1.3M EUR | 7 |
| 2019 | - | 470K EUR | -286K EUR | -1.3M EUR | 6 |
| 2018 | - | -949K EUR | -1.9M EUR | -3M EUR | 8 |
| 2017 | - | -3.9M EUR | -5M EUR | -1.2M EUR | 10 |
Official annual report
Find more companies like Aristo Pharma Nordic ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
As of December 11, 2021, AIDER Godkendt Revisionsaktieselskab has been appointed auditor of Aristo Pharma Nordic ApS.
As of December 11, 2021, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Aristo Pharma Nordic ApS.
As of August 30, 2021, Kenneth Pedersen has joined the board of directors of Aristo Pharma Nordic ApS.
As of August 18, 2021, Christian Jaaks has left the board of directors of Aristo Pharma Nordic ApS.
As of August 18, 2021, Kenneth Pedersen is registered as director of Aristo Pharma Nordic ApS.
As of August 18, 2021, Sascha Rauschke has stepped down as director of Aristo Pharma Nordic ApS.
Aristo Pharma Nordic ApS has published its annual report for 2020. Gross profit came to DKK 805,029, and the net result was DKK 62,127.
As of March 15, 2021, Christian Jaaks has joined the board of directors of Aristo Pharma Nordic ApS.
As of March 15, 2021, John Hudson Kriwet has joined the board of directors of Aristo Pharma Nordic ApS.
As of March 15, 2021, Hasnain Nasir Butt has left the board of directors of Aristo Pharma Nordic ApS.
About Aristo Pharma Nordic ApS
Aristo Pharma Nordic ApS is a Danish company of the type Anpartsselskab based in Skovlunde, founded in 2011. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named AMNEAL NORDIC ApS and COPHARMA ApS. The management consists of John Hudson Kriwet. The board consists of John Hudson Kriwet (chair), Jannes Paul Beeskow and Robert Maciej Szymanski. The company is owned by Aristo Pharma GmbH. The company has 1 employee (2026). In 2025, the company reported revenue of EUR 453,392 and a net result of EUR 21,589 compared with EUR 25,190 the year before. Equity in the 2025 report amounted to EUR 184,874.